234 related articles for article (PubMed ID: 21303347)
1. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
[TBL] [Abstract][Full Text] [Related]
2. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
Marchesini N; Luberto C; Hannun YA
J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
Ito H; Murakami M; Furuhata A; Gao S; Yoshida K; Sobue S; Hagiwara K; Takagi A; Kojima T; Suzuki M; Banno Y; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Nozawa Y; Murate T
Biochim Biophys Acta; 2009; 1789(11-12):681-90. PubMed ID: 19698806
[TBL] [Abstract][Full Text] [Related]
4. Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein.
Krut O; Wiegmann K; Kashkar H; Yazdanpanah B; Krönke M
J Biol Chem; 2006 May; 281(19):13784-13793. PubMed ID: 16517606
[TBL] [Abstract][Full Text] [Related]
5. Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells.
Clarke CJ; Guthrie JM; Hannun YA
Mol Pharmacol; 2008 Oct; 74(4):1022-32. PubMed ID: 18653803
[TBL] [Abstract][Full Text] [Related]
6. Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2.
Clarke CJ; Truong TG; Hannun YA
J Biol Chem; 2007 Jan; 282(2):1384-96. PubMed ID: 17085432
[TBL] [Abstract][Full Text] [Related]
7. Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase.
Clarke CJ; Mediwala K; Jenkins RW; Sutton CA; Tholanikunnel BG; Hannun YA
J Biol Chem; 2011 Jun; 286(24):21565-76. PubMed ID: 21536668
[TBL] [Abstract][Full Text] [Related]
8. Neutral sphingomyelinases and nSMase2: bridging the gaps.
Clarke CJ; Hannun YA
Biochim Biophys Acta; 2006 Dec; 1758(12):1893-901. PubMed ID: 16938269
[TBL] [Abstract][Full Text] [Related]
9. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.
Marchesini N; Osta W; Bielawski J; Luberto C; Obeid LM; Hannun YA
J Biol Chem; 2004 Jun; 279(24):25101-11. PubMed ID: 15051724
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells.
Chen CC; Sun YT; Chen JJ; Chang YJ
Mol Pharmacol; 2001 Mar; 59(3):493-500. PubMed ID: 11179444
[TBL] [Abstract][Full Text] [Related]
12. Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle.
Moylan JS; Smith JD; Wolf Horrell EM; McLean JB; Deevska GM; Bonnell MR; Nikolova-Karakashian MN; Reid MB
Redox Biol; 2014; 2():910-20. PubMed ID: 25180167
[TBL] [Abstract][Full Text] [Related]
13. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.
Jenkins RW; Canals D; Idkowiak-Baldys J; Simbari F; Roddy P; Perry DM; Kitatani K; Luberto C; Hannun YA
J Biol Chem; 2010 Nov; 285(46):35706-18. PubMed ID: 20807762
[TBL] [Abstract][Full Text] [Related]
14. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
15. Neutral sphingomyelinase 2 regulates inflammatory responses in monocytes/macrophages induced by TNF-α.
Al-Rashed F; Ahmad Z; Thomas R; Melhem M; Snider AJ; Obeid LM; Al-Mulla F; Hannun YA; Ahmad R
Sci Rep; 2020 Oct; 10(1):16802. PubMed ID: 33033337
[TBL] [Abstract][Full Text] [Related]
16. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death.
Liu B; Andrieu-Abadie N; Levade T; Zhang P; Obeid LM; Hannun YA
J Biol Chem; 1998 May; 273(18):11313-20. PubMed ID: 9556624
[TBL] [Abstract][Full Text] [Related]
17. Enriched Expression of Neutral Sphingomyelinase 2 in the Striatum is Essential for Regulation of Lipid Raft Content and Motor Coordination.
Tan LH; Tan AJ; Ng YY; Chua JJ; Chew WS; Muralidharan S; Torta F; Dutta B; Sze SK; Herr DR; Ong WY
Mol Neurobiol; 2018 Jul; 55(7):5741-5756. PubMed ID: 29043558
[TBL] [Abstract][Full Text] [Related]
18. Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium.
Kim SK; Ahn KH; Ji JE; Choi JM; Jeon HJ; Jung SY; Jung KM; Kim DK
Cell Signal; 2010 May; 22(5):865-70. PubMed ID: 20096352
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
[TBL] [Abstract][Full Text] [Related]
20. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway.
Adam D; Wiegmann K; Adam-Klages S; Ruff A; Krönke M
J Biol Chem; 1996 Jun; 271(24):14617-22. PubMed ID: 8663014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
